-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114.O1.6 114. Hemoglobinopathies, Excluding Thalassemia—Clinical: Hydroxyurea for Sickle Cell Disease: Treatment Benefits and Potential Reproductive Risks for Women

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Anemias, Coronaviruses, SARS-CoV-2/COVID-19, sickle cell disease, Diseases, Non-Biological, Therapies, Pediatric, Hemoglobinopathies, Young Adult, Study Population, Clinically relevant
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Moderators:
Omar Niss, MD, Cincinnati Children's Hospital and Venee N. Tubman, MD, Texas Children's Cancer and Hematology Centers
Disclosures:
No relevant conflicts of interest to declare.
7:30 AM

Shehu Umar Abdullahi, MBBS1*, Binta W. Jibir, MBBS2*, Halima Bello-Manga, MBBS, MPH, FMCPath3, Safiya Gambo, MBBS, FWACP4*, Hauwa Inuwa, MBBS5*, Aliyu Gaya Tijjani, MBBS6*, Aisha Amal Galadanci, MBBS7*, Awwal Musa Borodo, MBBS, FMCPath8*, Najibah Aliyu Galadanci, MBBS, MPH9, Nura Idris, MBBS, FWACS6*, Abulkadir M Tabari, MBBS, FMCR, FICS10*, Lawal Haliru, MBBS11*, Khadija Bulama, BNSc12*, Gloria Bahago, RN13*, Mohammed A. Sani, B. Pharm, MSc14*, Aisha Suleiman, MBBS13*, Murtala Umar, B. Pharm14*, Charity Dooshima, Agba, B. Pharm15*, Aisha Kazaure, B. Pharm16*, Bilya Sani Musa, BSc, MPPA, MHE12*, Fahad M Usman, BSc12*, Abdulrasheed Sani, MIM13*, Awwal Gambo, PGDM, MDS6*, Jamila S. Ibrahim, MBBS, MScPH, PMCPead17*, Mustapha Hikima, MBBS, FWACP18*, Aisha B. Musa, MBBS5*, Abdu H. Dambatta, MBBS, FWACP19*, Jamil Aliyu Galadanci, BSc, MSc20*, Brittany Covert Greene, MPH, CCRP21*, Djamila Labib Ghafuri, MPH22*, Mark Rodeghier, PhD23*, James Slaughter, PhD24*, Fenella Jane Kirkham, MD25*, Kathleen Neville, MD, MS, FAAP, FCCP26*, Adetola A. Kassim, MD, MS27, Muktar Aliyu, MBBS, DrPH, MPH28*, Lori C. Jordan, MD, PhD29*, Edwin Trevathan, MD, MPH30* and Michael R. DeBaun, MD, MPH31

1Pediatrics, Bayero University/Aminu Kano Teaching hospital, Kano, Nigeria
2Hasiya Bayero Specialist Hospital, Kano, Nigeria
3Barau Dikko Teaching Hospital, Kaduna State University, Kaduna, NGA
4Murtala Mohammed Specialist Hospital, Kano, Nigeria
5Department of Pediatrics, Aminu Kano Teaching Hospital, Kano, Nigeria
6Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria
7Department of Hematology and Blood Transfusion, Aminu Kano Teaching Hospital Kano, Kano, NGA
8Department of Medicine, Murtala Mohammed Specialist Hospital, Kano, Nigeria
9School of Public Health/Epidemiology, University of Alabama at Birmingham, Birmingham, AL
10Department of Radiology, Barau Dikko Teaching Hospital, Kaduna, Nigeria
11Department of Pediatrics, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria
12Department of Administration, Aminu Kano Teaching Hospital, Kano, Nigeria
13Department of Pediatrics, Barau Dikko Teaching Hospital, Kaduna, Nigeria
14Department of Pharmacy, Aminu Kano Teaching Hospital, Kano, Nigeria
15Department of Pharmacy, Murtala Mohammed Specialist Hospital, Kano, Nigeria
16Department of Pharmacy, Barau Dikko Teaching Hospital, Kaduna, Nigeria
17Department of Pediatrics, Mohammed Abdullahi Wase Specialist Hospital, Kano, Nigeria
18Department of Radiology, Mohammed Abdullahi Wase Specialist Hospital, Kano, Nigeria
19Department of Radiology, Aminu Kano Teaching Hospital, Kano, Nigeria
20Department of Computer Science, Bayero University, Kano, Nigeria
21Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN
22Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville
23Statistical Consultant, Rodeghier Consultants, Chicago, IL
24Department of Biostatistics, Vanderbilt University Medical Center, Nashville
25Department of Pediatrics, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
26PEDIATRICS, University of Arkansas for Medical Sciences/Arkansas Children’s Hospital, LITTLE ROCK, AR
27Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
28VANDERBILT INSTITUTE FOR GLOBAL HEALTH, VANderbilt University School of Medicine, NASHVILLE, TN
29Department of Pediatrics, Pediatric Neurology, Vanderbilt University School of Medicine, Nashville, TN
30PEDIATRICS, Vanderbilt Institute for Global Health, VANDERBILT UNIVERSITY MEDICAL CENTER, NASHVILLE, TN
31Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease, Vanderbilt University School of Medicine, Nashville, TN

7:45 AM

Shehu Umar Abdullahi, MBBS1*, Surayya M. Sunusi2*, Mohammed Sani Abba3*, Saifuddeen Sani4*, Aisha Galadanci, MBBS5*, Hauwa Inuwa, MBBS6*, Binta W. Jibir, MBBS7*, Brittany Covert Greene, MPH, CCRP8*, Adetola A. Kassim, MD, MS9, Lori C. Jordan, MD, PhD10*, Muktar Aliyu, MBBS, DrPH, MPH11*, Mark Rodeghier, PhD12*, Awwal Musa Borodo, MBBS, FMCPath13*, Bilya Sani Musa, BSc, MPPA, MHE4*, Habu Abdu5* and Michael R. DeBaun, MD, MPH14

1Pediatrics, Bayero University/Aminu Kano Teaching hospital, Kano, Kano, Nigeria
2Department of Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria
3Department of Pharmacy, Aminu Kano Teaching Hospital, Kano, Nigeria
4Department of Administration, Aminu Kano Teaching Hospital, Kano, Nigeria
5Department of Hematology and Blood Transfusion, Aminu Kano Teaching Hospital, Kano, Nigeria
6Department of Pediatrics, Aminu Kano Teaching Hospital, Kano, Nigeria
7pediatrics, Murtala Mohammed specialist hospital, Kano, Nigeria
8Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Nashville, TN
9Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
10Department of Pediatrics, Pediatric Neurology, Vanderbilt University School of Medicine, Nashville, TN
11VANDERBILT INSTITUTE FOR GLOBAL HEALTH, VANderbilt University School of Medicine, NASHVILLE, TN
12Statistical Consultant, Rodeghier Consultants, Chicago, IL
13Department of Medicine, Murtala Mohammed Specialist Hospital, Kano, Nigeria
14Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease, Vanderbilt University School of Medicine, Nashville, TN

8:00 AM

Lydia H. Pecker, MD1, Sarah Hussain2*, Jaanvi Mahesh2*, Ravi Varadhan, PhD3*, Mindy S Christianson, MD, MBA4* and Sophie M. Lanzkron, MD, MHS5

1Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
2Johns Hopkins University, Baltimore
3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
4Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins Univeristy School of Medicine, Baltimore, MD
5Department of Medicine, Division of Hematology, Johns Hopkins Medicine, Baltimore, MD

8:15 AM

Lana Mucalo, MD1*, Amanda M. Brandow, DO, MS1, Sadie F. Mason, MD1*, Ashima Singh, PhD, MS1, Bradley W. Taylor, FAMIA1*, Katherine J. Woods, MS1*, Fouza I. Yusuf, MS, MPH1* and Julie Panepinto, MD, MS2

1Medical College of Wisconsin, Milwaukee, WI
2The Medical College of WI, Milwaukee, WI

8:30 AM

Fuad A El Rassi, MD1, John James, MSc2*, Biree Andemariam, MD3, Baba PD Inusa, MD, MBBS4, Beverley Francis-Gibson, MA5*, Alecia C Nero, MD6*, Caterina P. Minniti, MD7, Cassandra Trimnell, BA8*, Miguel R Abboud, MD9, Jean-Benoît Arlet, MD10*, Raffaella Colombatti, MD, PhD11, Mariane de Montalembert, MD, PhD12*, Suman Jain, MD13*, Wasil Jastaniah, MD14*, Erfan Nur, MD, PhD15, Marimilia Pita, MD16*, Nicholas Ramscar, MBBS17*, Tom Bailey, MSci18*, Olivera Rajkovic-Hooley, PhD18* and Ifeyinwa Osunkwo, MD, MPH19*

1Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta, GA
2Sickle Cell Society, London, United Kingdom
3New England Sickle Cell Institute at the University of Connecticut, Farmington, CT
4Evelina Children's Hospital and Guy’s and St Thomas’ Hospital, London, United Kingdom
5Sickle Cell Disease Association of America, Baltimore, MD
6University of Texas Southwestern Medical Center, Dallas, TX
7Albert Einstein College of Medicine, New York, NY
8Sickle Cell 101, San Jose, CA
9American University of Beirut Medical Center, Beirut, Lebanon
10Hôpital Européen Georges-Pompidou, Paris, France
11Azienda Ospedale-Università di Padova, Padova, Italy
12Hôpital Universitaire Necker-Enfants Malades, Paris, France
13Thalassemia and Sickle Cell Society, Hyderabad, India
14Umm Al-Qura University, Mecca, Saudi Arabia
15Academic Medical Center, Amsterdam, Netherlands
16Laureate University-UAM, Pediatric-Hematology, Hospital Samaritano, São Paulo, Brazil
17Novartis Pharma AG, Basel, Switzerland
18Adelphi Real World, Bollington, United Kingdom
19Sickle Cell Disease Enterprise at the Levine Cancer Institute/Atrium Health, Charlotte, NC

*signifies non-member of ASH